These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 29689304

  • 1. Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma.
    Chinello C, Stella M, Piga I, Smith AJ, Bovo G, Varallo M, Ivanova M, Denti V, Grasso M, Grasso A, Del Puppo M, Zaravinos A, Magni F.
    J Proteomics; 2019 Jan 16; 191():29-37. PubMed ID: 29689304
    [Abstract] [Full Text] [Related]

  • 2. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V, Pereira Dde A, Kalume DE, Oliveira-Carvalho AL, Ornellas AA, Soares MR, Alves G, Zingali RB.
    Urol Oncol; 2016 Jan 16; 34(1):5.e11-25. PubMed ID: 26420021
    [Abstract] [Full Text] [Related]

  • 3. Blood- and Urine-Based Liquid Biopsy for Early-Stage Cancer Investigation: Taken Clear Renal Cell Carcinoma as a Model.
    Liu X, Zhang M, Shao C, Sun H, Zhang B, Guo Z, Sun J, Qi F, Zhang Y, Niu H, Sun W.
    Mol Cell Proteomics; 2023 Aug 16; 22(8):100603. PubMed ID: 37348606
    [Abstract] [Full Text] [Related]

  • 4. Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades.
    Stella M, Chinello C, Cazzaniga A, Smith A, Galli M, Piga I, Grasso A, Grasso M, Del Puppo M, Varallo M, Bovo G, Magni F.
    J Proteomics; 2019 Jan 16; 191():38-47. PubMed ID: 29698802
    [Abstract] [Full Text] [Related]

  • 5. Searching for prognostic biomarkers for small renal masses in the urinary proteome.
    Di Meo A, Batruch I, Brown MD, Yang C, Finelli A, Jewett MA, Diamandis EP, Yousef GM.
    Int J Cancer; 2020 Apr 15; 146(8):2315-2325. PubMed ID: 31465112
    [Abstract] [Full Text] [Related]

  • 6. Pathway analysis of kidney cancer using proteomics and metabolic profiling.
    Perroud B, Lee J, Valkova N, Dhirapong A, Lin PY, Fiehn O, Kültz D, Weiss RH.
    Mol Cancer; 2006 Nov 24; 5():64. PubMed ID: 17123452
    [Abstract] [Full Text] [Related]

  • 7. Use of quantitative shotgun proteomics to identify fibronectin 1 as a potential plasma biomarker for clear cell carcinoma of the kidney.
    Yokomizo A, Takakura M, Kanai Y, Sakuma T, Matsubara J, Honda K, Naito S, Yamada T, Ono M.
    Cancer Biomark; 2006 Nov 24; 10(3-4):175-83. PubMed ID: 22674303
    [Abstract] [Full Text] [Related]

  • 8. Chromophobe Renal Cell Carcinoma With Retrograde Venous Invasion and Gain of Chromosome 21: Potential Harbingers of Aggressive Clinical Behavior.
    Jamal M, Taneja K, Arora S, Barod R, Rogers CG, Sanchez J, Gupta NS, Williamson SR.
    Int J Surg Pathol; 2018 Sep 24; 26(6):536-541. PubMed ID: 29560759
    [Abstract] [Full Text] [Related]

  • 9. Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.
    Yang J, Liu P, Tian M, Li Y, Chen W, Li X.
    Int J Oncol; 2013 Jun 24; 42(6):2078-86. PubMed ID: 23588948
    [Abstract] [Full Text] [Related]

  • 10. Prognostic evaluation of perinephric fat, renal sinus fat, and renal vein invasion for patients with pathological stage T3a clear-cell renal cell carcinoma.
    Shah PH, Lyon TD, Lohse CM, Cheville JC, Leibovich BC, Boorjian SA, Thompson RH.
    BJU Int; 2019 Feb 24; 123(2):270-276. PubMed ID: 30113768
    [Abstract] [Full Text] [Related]

  • 11. Retrograde venous invasion in renal cell carcinoma: a complication of sinus vein and main renal vein invasion.
    Bonsib SM, Bhalodia A.
    Mod Pathol; 2011 Dec 24; 24(12):1578-85. PubMed ID: 21822202
    [Abstract] [Full Text] [Related]

  • 12. [Preliminary analysis of differentially expressed proteins of clear-cell renal cell carcinoma by comparative proteomic technologies].
    Yang J, Li X, Tian MJ, Wang LN, Cheng TT, Chen W.
    Zhonghua Zhong Liu Za Zhi; 2012 Aug 24; 34(8):571-6. PubMed ID: 23158988
    [Abstract] [Full Text] [Related]

  • 13. Comparative membrane proteomics: a technical advancement in the search of renal cell carcinoma biomarkers.
    Raimondo F, Corbetta S, Savoia A, Chinello C, Cazzaniga M, Rocco F, Bosari S, Grasso M, Bovo G, Magni F, Pitto M.
    Mol Biosyst; 2015 Jun 24; 11(6):1708-16. PubMed ID: 25926002
    [Abstract] [Full Text] [Related]

  • 14. iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma.
    Zhang L, Jiang H, Xu G, Chu N, Xu N, Wen H, Gu B, Liu J, Mao S, Na R, Jing Y, Ding Q, Zhang Y, Wang L.
    Biosci Trends; 2016 Jul 19; 10(3):210-9. PubMed ID: 27319973
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B, Patard JJ, Méjean A, Bensalah K, Verhoest G, Zigeuner R, Ficarra V, Tostain J, Mulders P, Chautard D, Descotes JL, de la Taille A, Salomon L, Prayer-Galetti T, Cindolo L, Valéri A, Meyer N, Jacqmin D, Lang H.
    Eur Urol; 2009 Feb 19; 55(2):452-9. PubMed ID: 18692951
    [Abstract] [Full Text] [Related]

  • 16. 14-3-3 protein beta/alpha as a urinary biomarker for renal cell carcinoma: proteomic analysis of cyst fluid.
    Minamida S, Iwamura M, Kodera Y, Kawashima Y, Tabata K, Matsumoto K, Fujita T, Satoh T, Maeda T, Baba S.
    Anal Bioanal Chem; 2011 Jul 19; 401(1):245-52. PubMed ID: 21553213
    [Abstract] [Full Text] [Related]

  • 17. Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms.
    Koch E, Finne K, Eikrem Ø, Landolt L, Beisland C, Leh S, Delaleu N, Granly M, Vikse BE, Osman T, Scherer A, Marti HP.
    Am J Physiol Renal Physiol; 2019 May 01; 316(5):F1053-F1067. PubMed ID: 30838877
    [Abstract] [Full Text] [Related]

  • 18. Impact of Microscopic Wall Invasion of the Renal Vein or Inferior Vena Cava on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus: A Multi-institutional Analysis from the International Renal Cell Carcinoma-Venous Thrombus Consortium.
    Rodriguez Faba O, Linares E, Tilki D, Capitanio U, Evans CP, Montorsi F, Martínez-Salamanca JI, Libertino J, Gontero P, Palou J.
    Eur Urol Focus; 2018 Apr 01; 4(3):435-441. PubMed ID: 28753848
    [Abstract] [Full Text] [Related]

  • 19. Label-free quantitative proteomic analysis reveals potential biomarkers and pathways in renal cell carcinoma.
    Zhao Z, Wu F, Ding S, Sun L, Liu Z, Ding K, Lu J.
    Tumour Biol; 2015 Feb 01; 36(2):939-51. PubMed ID: 25315187
    [Abstract] [Full Text] [Related]

  • 20. Comparative studies of the proteome, glycoproteome, and N-glycome of clear cell renal cell carcinoma plasma before and after curative nephrectomy.
    Gbormittah FO, Lee LY, Taylor K, Hancock WS, Iliopoulos O.
    J Proteome Res; 2014 Nov 07; 13(11):4889-900. PubMed ID: 25184692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.